Valuation: Omnicell, Inc.

Market Cap 1.67B 1.5B 1.38B 1.25B 2.33B 159B 2.38B 16.42B 6.59B 83.5B 6.27B 6.14B 263B P/E 2026 *
32.9x
P/E 2027 * 39.1x
Enterprise Value 1.67B 1.5B 1.38B 1.25B 2.33B 159B 2.38B 16.42B 6.59B 83.5B 6.27B 6.14B 263B EV / Sales 2026 *
1.36x
EV / Sales 2027 * 1.34x
Free-Float
76.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.62%
1 week-2.91%
1 month+7.64%
3 months+3.62%
6 months-11.52%
Current year-19.09%
1 week 35.45
Extreme 35.45
38.5
1 month 33.07
Extreme 33.07
38.5
Current year 31.75
Extreme 31.75
55
1 year 31.75
Extreme 31.75
55
3 years 22.66
Extreme 22.66
55.74
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 2002-09-30
Director of Finance/CFO 56 2025-09-14
President 50 2026-06-30
Director TitleAgeSince
Chairman 68 1992-08-31
Director/Board Member 70 2012-12-31
Director/Board Member 70 2013-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/17/26 Sell

Chairperson

-3,083 0.0068%
8/15/26 Tax

Chief Executive Officer

-12,350 0.0272%
8/15/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%-2.91%+9.17%+3.12% 1.67B
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-.--%+2.46%-11.69%-7.41% 53.31B
-2.57%+3.30%+11.59%+44.40% 53.03B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.47%+1.04%+19.48%+69.17% 49.3B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -1.85%-0.56%+2.16%+39.01% 88.57B
Weighted average by Cap. -2.10%+0.15%+4.04%+44.57%

Financials

2026 *2027 *
Net sales 1.23B 1.1B 1.01B 917M 1.71B 117B 1.75B 12.07B 4.84B 61.36B 4.61B 4.51B 193B 1.25B 1.12B 1.03B 931M 1.74B 118B 1.77B 12.25B 4.92B 62.27B 4.68B 4.58B 196B
Net income 51.98M 46.55M 42.82M 38.8M 72.52M 4.94B 73.88M 511M 205M 2.6B 195M 191M 8.19B 44.05M 39.45M 36.29M 32.88M 61.46M 4.18B 62.61M 433M 174M 2.2B 165M 162M 6.94B
Net Debt - -
Projected Income Statement - Annual - Omnicell, Inc.
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,580
Date Price Change Volume
26-10-30 $36.65 -0.62% 785,543
26-10-29 $36.88 +2.59% 841,786
26-10-28 $35.95 -2.20% 936,986
26-10-27 $36.76 -0.57% 581,008
26-10-26 $36.97 -2.07% 539,739
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
MarketScreener Ratings - Omnicell, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
36.65USD
Average target price
57.71USD
Spread / Average Target
+57.47%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Omnicell, Inc.
  1. Stock Market
  2. Stocks
  3. OMCL Stock